SciELO - Scientific Electronic Library Online

 
vol.5 número14Calidad de vida y salud en pueblos indígenas amazónicos durante la pandemia COVID-19Fortalecimiento muscular de cadera y rodilla en el síndrome doloroso patelofemoral: Revisión sistemática y metaanálisis índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Vive Revista de Salud

versión impresa ISSN 2664-3243

Resumen

TOAQUIZA, Myrian Doris Cayo; FLOREANO, Diana Lourdes Ponce; CASTRO, Jazmin Elena  y  JALCA, Alexander Dario Castro. Reticulocyte hemoglobin and its clinical utility in the early diagnosis of erythropoiesis due to absolute iron deficiency in adolescent women. Vive Rev. Salud [online]. 2022, vol.5, n.14, pp.337-347.  Epub 22-Jun-2022. ISSN 2664-3243.  https://doi.org/10.33996/revistavive.v5i14.152.

Reticulocyte hemoglobin is a new parameter within the fourth generation hematological autoanalyzers, being indispensable in the diagnosis and management of iron deficient erythropoiesis, especially functional iron deficiency, iron sequestration and absolute iron deficiency. Moreover, this parameter proves to be more accurate than biochemical tests such as serum iron, ferritin and transferrin saturation in the early detection of iron deficient erythropoiesis. The aim of the research was to describe the clinical utility of reticulocyte hemoglobin (CHr) in the early diagnosis of absolute iron deficiency erythropoiesis in adolescent females. The type of research was descriptive, analytical, cross-sectional field design. The voluntary, non-random sample consisted of 62 adolescent females aged between 14 and 19 years. As a result, it was found that 97% of the sample had decreased CHr, indicating iron deficient erythropoiesis, while 3% of the adolescents had normal values for CHr. The diagnostic relationship between laboratory tests such as CHr and serum iron was performed. It was also reported that 93% of the sample presented iron deficiency without anemia, and 7% had iron deficiency anemia; the age range with the highest prevalence of iron deficiency anemia was between 14 and 16 years of age. It is concluded that HRH is clinically useful and a new tool for early diagnosis of erythropoiesis due to iron deficiency.

Palabras clave : Reticulocyte hemoglobin; Iron deficient erythropoiesis; Absolute iron deficiency; Hemogram; Anemia.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )